<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle21
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle24
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle25
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle26
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle27
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle28
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle29
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle30
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle31
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle32
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle33
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle34
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle35
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle36
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle37
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-AU" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><b><u><span style="font-size:12.0pt;color:#1F4E79">CONFERENCE ANNOUNCEMENT: CALL FOR PAPERS</span></u></b><b><u><span style="font-size:12.0pt;color:#1F497D"><o:p></o:p></span></u></b></p>
<p class="MsoNormal"><b><u><span style="color:#1F497D"><o:p><span style="text-decoration:none"> </span></o:p></span></u></b></p>
<p class="MsoNormal"><span style="color:#1F4E79">‘</span><span style="color:#1F497D">Making
</span><span style="color:#1F4E79">alcohol and other drug</span><span style="color:#1F497D"> realities</span><span style="color:#1F4E79">’<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">23-25</span><span style="color:#1F4E79">
</span><span style="color:#1F497D">August,</span><span style="color:#1F4E79"> 201</span><span style="color:#1F497D">7</span><span style="color:#1F4E79"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Helsinki</span><span style="color:#1F4E79">,
</span><span style="color:#1F497D">Finland<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="color:#1F4E79">CLOSING DATE FOR ABSTRACT SUBMISSION – 1</span><span style="color:#1F497D">
</span><span style="color:#1F4E79">MARCH</span><span style="color:#1F497D">,</span><span style="color:#1F4E79"> 201</span><span style="color:#1F497D">7<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US" style="color:#1F497D"><img width="384" height="160" style="width:4.0in;height:1.6666in" id="Picture_x0020_3" src="cid:image001.jpg@01D23526.DE31CA00"></span><span style="color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Dear</span><span style="color:#1F497D"> colleagues,</span><span style="color:#1F4E79"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Please see the attached flyer for further details on the conference theme,
</span><span style="color:#1F497D">venue, </span><span style="color:#1F4E79">format</span><span style="color:#1F497D"> and
</span><span style="color:#1F4E79">abstract submission.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Building on the three previous conferences run by<i> Contemporary Drug Problems</i>, which have opened up questions of how drugs are problematised; how the complexity of drug use might be attended to and managed;
and how drug use might be understood as event, assemblage or phenomenon, <b>we now seek submissions for presentations that critically explore and debate the issues posed when we approach science, policy, treatment, law and other practices as constituting the
realities they seek to address</b>.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Please forward this email to interested colleagues and relevant email lists.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">With many thanks and apologies in advance for cross-postings</span><span style="color:#1F497D">,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">David Moore</span><span style="color:#1F497D"> Pekka Hakkarainen</span><span style="color:#1F4E79"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Editor National Institute for Health and Welfare<o:p></o:p></span></p>
<p class="MsoNormal"><i><span style="color:#1F497D">Contemporary Drug Problems</span></i><span style="color:#1F497D"> Finland<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">On behalf of the Conference Committee:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Kim Bloomfield (<i>Contemporary Drug Problems</i> & Centre for Alcohol and Drug Research, Aarhus University, Denmark)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Nancy Campbell (<i>Contemporary Drug Problems</i> & Department of Science and Technology Studies, Rensselaer Polytechnic Institute, USA)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Suzanne Fraser </span><span lang="EN-US" style="color:#1F4E79">(</span><i><span style="color:#1F4E79">Contemporary Drug Problems</span></i><span style="color:#1F4E79"> & National Drug Research Institute, Curtin
University, Australia)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Pekka Hakkarainen</span><span style="color:#1F4E79"> (</span><span style="color:#1F497D">National Institute for Health and Welfare, Finland</span><span style="color:#1F4E79">)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Kati Kataja (National Institute for Health and Welfare, Finland)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">David Moore (<i>Contemporary Drug Problems</i> & National Drug Research Institute, Curtin University, Australia)<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F4E79">Mark Stoové (<i>Contemporary Drug Problems</i> & Burnet Institute, Australia)<o:p></o:p></span></p>
</div>
</body>
</html>